ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

No Benefit To Shark Cartilage As Treatment, Large Trial Finds

July 27, 2007

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986

NIH Seeks Method For Allocating Research Funds, Determine Economic Impact By Disease Category

April 26, 1974

NCCN Updates Myeloma Clinical Practice Guidelines

September 26, 2003

Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds

July 28, 2006

In Brief: Weissman Heads DCBD Board; Extra Money For Grants Lifts Funding Level To 35%

October 14, 1977